Abstract
The use of trivial names for enkephalin degrading peptidases such as "aminoenkephalinase" and "carboxyenkephalinase" imply a specificity and cellular localization which is not inherent in any of the peptidases implicated in the degradation of endogenous enkephalins. Rather than name these enzymes on the basis of one of their many substrates, it is proposed that they be named according to their general reaction type. Such a nomenclature has already been proposed for the enkephalin degrading endopeptidase 24.11 given the trivial name "enkephalinase".
| Original language | English |
|---|---|
| Pages (from-to) | 1151-1153 |
| Number of pages | 3 |
| Journal | Life Sciences |
| Volume | 38 |
| Issue number | 13 |
| DOIs | |
| State | Published - Mar 31 1986 |
Bibliographical note
Funding Information:This study was supported in part by Grant No. DA02243 from NIDA and Grant No. 1391 from the Welch Foundation, Houston, Texas.
Funding
This study was supported in part by Grant No. DA02243 from NIDA and Grant No. 1391 from the Welch Foundation, Houston, Texas.
| Funders | Funder number |
|---|---|
| National Institute on Drug Abuse | R01DA002243 |
| Welch Foundation | |
| National Institute of Development Administration | 1391 |
ASJC Scopus subject areas
- General Pharmacology, Toxicology and Pharmaceutics
- General Biochemistry, Genetics and Molecular Biology